23:31 min
CLEAR ALL
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.
1
Roland R. Griffiths, Ph.D. is a psychopharmacologist who serves as a professor and research coordinator at the Johns Hopkins University School of Medicine. This interview was captured during the Psychedemia conference at the University of Pennsylvania in September 2012.
In this edited version of Roland Griffith’s very information talk on Psilocybin (original title “The science of psilocybin and its use to relieve suffering”) we take a look at the amazing positive effects achieved with this controversial substance.
This presentation summarizes past and ongoing studies from the Johns Hopkins Psilocybin Research Project, which started about 15 years ago.
Dr. Roland R. Griffiths is a clinical pharmacologist at Johns Hopkins. Dr. Griffiths has been researching mood-altering compounds for over 40 years, has published over 360 times, and started the psilocybin research program at Johns Hopkins nearly 2 decades ago.
Bestselling author Tim Ferriss (Tools of Titans, The 4-Hour Workweek, etc.) probes the science, mysteries, and future of psychedelics with Dr. Roland R. Griffiths, a clinical pharmacologist at Johns Hopkins. Dr.
The talk will review brain imaging work on the action of psychedelics on the brain and describe the results of a clinical trial assessing psilocybin as a treatment for depression. It will also review the broader societal impact of psychedelic drug-use and discuss its implications.